Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model

被引:15
|
作者
Higham, Eileen M. [1 ,2 ]
Shen, Ching-Hung [1 ,4 ]
Wittrup, K. Dane [1 ,2 ,3 ]
Chen, Jianzhu [1 ,4 ]
机构
[1] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[2] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[3] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[4] MIT, Dept Biol, Cambridge, MA 02139 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
IMMUNITY; VACCINATION; CANCER; LYMPHOCYTES; GLIOMA;
D O I
10.4049/jimmunol.1000265
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor environment exerts a powerful suppressive influence on infiltrating tumor-reactive T cells. It induces tolerance of adoptively transferred effector T cells as they enter tumors and maintains the tolerance of persisting tumor-infiltrating T cells. In an autochthonous prostate cancer model, in which tumor-reactive CD8 T cells are trackable, we demonstrate that both depletion of endogenous dendritic cells (DCs) and intratumoral injection of Ag-loaded mature DCs delayed the tolerization of tumor-infiltrating effector CD8 T cells. Intratumoral injection of Ag-loaded DCs also reactivated tolerized CD8 T cells in the tumor tissue. The observed effects lasted as long as the injected DCs persisted. These findings are consistent with a critical role of DCs in modulating T cell reactivity in the tumor environment. They also suggest new potential strategies to extend the functionality of transferred effector T cells and to restore function to tolerized tumor-infiltrating T cells for cancer immunotherapy. The Journal of Immunology, 2010, 184: 5954-5958.
引用
收藏
页码:5954 / 5958
页数:5
相关论文
共 33 条
  • [21] Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapy
    Simon, Thomas
    Fonteneau, Jean-Francois
    Gregoire, Marc
    IMMUNOTHERAPY, 2013, 5 (06) : 565 - 567
  • [22] CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor
    Ghorashian, Sara
    Velica, Pedro
    Chua, Ignatius
    McNicol, Anne-Marie
    Ben Carpenter
    Holler, Angelika
    Nicholson, Emma
    Ahmadi, Maryam
    Zech, Mathias
    Xue, Shao-An
    Uckert, Wolfgang
    Morris, Emma
    Chakraverty, Ronjon
    Stauss, Hans J.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (03) : 1080 - 1089
  • [23] Splenic Dendritic Cells Involved in Cross-Tolerance of Tumor Antigens Can Play a Stimulatory Role in Adoptive T-Cell Therapy
    Gibbins, John D.
    Ancelet, Lindsay R.
    Osmond, Taryn L.
    Petersen, Troels R.
    Hermans, Ian F.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (08) : 321 - 329
  • [24] The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
    Bowman-Kirigin, Jay A.
    Desai, Rupen
    Saunders, Brian T.
    Wang, Anthony Z.
    Schaettler, Maximilian O.
    Liu, Connor J.
    Livingstone, Alexandra J.
    Kobayashi, Dale K.
    Durai, Vivek
    Kretzer, Nicole M.
    Zipfel, Gregory J.
    Leuthardt, Eric C.
    Osbun, Joshua W.
    Chicoine, Michael R.
    Kim, Albert H.
    Murphy, Kenneth M.
    Johanns, Tanner M.
    Zinselmeyer, Bernd H.
    Dunn, Gavin P.
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (01) : 20 - 37
  • [25] Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent
    Mallick, Atanu
    Barik, Subhasis
    Ghosh, Sarbari
    Roy, Soumyabrata
    Sarkar, Koustav
    Bose, Anamika
    Baral, Rathindranath
    IMMUNOTHERAPY, 2014, 6 (07) : 821 - 831
  • [26] Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells
    Lenogue, Kevin
    Walencik, Alexandre
    Laulagnier, Karine
    Molens, Jean-Paul
    Benlalam, Houssem
    Dreno, Brigitte
    Coulie, Pierre
    Pule, Martin
    Chaperot, Laurence
    Plumas, Joel
    VACCINES, 2021, 9 (02) : 1 - 15
  • [27] Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma
    Goforth, Robin
    Salem, Aliasger K.
    Zhu, Xiaoyan
    Miles, Suzanne
    Zhang, Xue-Qing
    Lee, John H.
    Sandler, Anthony D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (04) : 517 - 530
  • [28] CD8+ T-cell Clones Specific for the 5T4 Antigen Target Renal Cell Carcinoma Tumor-initiating Cells in a Murine Xenograft Model
    Tykodi, Scott S.
    Satoh, Shoko
    Deming, Janise D.
    Chou, Jeffrey
    Harrop, Richard
    Warren, Edus H.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (07) : 523 - 533
  • [29] Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors
    Goold, Hugh D.
    Escors, David
    Conlan, Thomas J.
    Chakraverty, Ronjon
    Bennett, Clare L.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (08) : 4565 - 4572
  • [30] RETRACTED: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells (Retracted article. See vol. 76, pg. 2490, 2016)
    Shafer-Weaver, Kimberly A.
    Watkins, Stephanie K.
    Anderson, Michael J.
    Draper, Lauren J.
    Malyguine, Anatoli
    Alvord, W. Gregory
    Greenberg, Norman M.
    Hurwitz, Arthur A.
    CANCER RESEARCH, 2009, 69 (15) : 6256 - 6264